FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

HOLT PAUL 		2. Issuer Name and Ticker or Trading Symbol

NantHealth, Inc. [ NH ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
Chief Financial Officer
(Last)          (First)          (Middle)

C/O NANTHEALTH, INC., 9920 JEFFERSON BLVD. 		3. Date of Earliest Transaction (MM/DD/YYYY)

5/1/2018
(Street)

CULVER CITY, CA 90232
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   5/1/2018     M    3974   A $0.00   56822   D    
Common Stock   5/1/2018     F    1374   D $3.39   55448   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Phantom Units     (1) 5/1/2018     M         3974      (2)   (2) Common Stock   3974   $0.00   7950   D    

Explanation of Responses:
(1)  Each share of phantom unit is the economic equivalent of one share of NantHealth, Inc. common stock.
(2)  Subject to the reporting person's continuing service, one-half (1/2) of the phantom units held by the reporting person vested on the June 7, 2016, and the remaining phantom units held by the reporting person shall vest in equal amounts each year beginning on May 1, 2017, such that the phantom units shall fully vest into shares of common stock on May 1, 2020.

Remarks:
Exhibit 24 - Power of Attorney

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
HOLT PAUL
C/O NANTHEALTH, INC.
9920 JEFFERSON BLVD.
CULVER CITY, CA 90232

Chief Financial Officer

Signatures
/s/ Brandon Villery, as Attorney-in-Fact 5/3/2018
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. 
                                                                      Exhibit 24



                                 POWER OF ATTORNEY

      The undersigned, as a Section 16 reporting person of NantHealth, Inc.
(the "Company"), hereby constitutes and appoints Patrick Soon-Shiong, Brandon
Villery, Charles Kim, Daniel R. Koeppen, Thomas Hornish, Kathryn Fortin, and
Martin J. Waters  the undersigned's true and lawful attorneys-in-fact to:

     1.     complete and execute Forms 3, 4 and 5 and other forms and all
            amendments thereto as such attorneys-in-fact shall in their
            discretion determine to be required or advisable pursuant to
            Section 16 of the Securities Exchange Act of 1934 (as amended) and
            the rules and regulations promulgated thereunder, or any
            successor laws and regulations, as a consequence of the
            undersigned's ownership, acquisition or disposition of securities
            of the Company; and

     2.     do all acts necessary in order to file such forms with the
            Securities and Exchange Commission, any securities exchange or
            national association, the Company and such other person or agency as
             the attorneys-in-fact shall deem appropriate.

      The undersigned, as a Section 16 reporting person of the Company, hereby
revokes any and all prior powers of attorney previously signed by the
undersigned.

      The undersigned hereby ratifies and confirms all that said attorneys-in-
fact and agent shall do or cause to be done by virtue hereof.  The undersigned
acknowledges that the foregoing attorneys-in-fact, in serving in such capacity
at the request of the undersigned, are not assuming, nor is the Company
assuming, any of the undersigned's responsibilities to comply with
Section 16 of the Securities Exchange Act of 1934 (as amended).

      This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
Company and the foregoing attorneys-in-fact.

      IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 2nd day of May, 2018.


                                              Signature: /s/ Paul Holt
                                                         -------------------

                                              Print Name:  Paul Holt
                                                         -------------------